Cowlpane has published 8 articles on m&a — primarily in Markets, Economy, Tech , with coverage from 2026. Sourced from global financial publications.
Major pharmaceutical giants accelerate biotech acquisitions to replace expiring revenue streams and stave off long-term growth erosion.
Element Fleet's cash offer for FleetPartners reshapes the Australian leasing landscape, signaling a shift toward scale in the vehicle management sector.
Investors flee AstraZeneca as doubts mount over a massive potential merger with Bristol Myers Squibb, threatening sector stability.
AstraZeneca explores a massive tie-up with Bristol Myers Squibb, a deal that would create the world's fourth-largest drugmaker.
AstraZeneca's potential takeover of Bristol Myers Squibb could create a $400B pharmaceutical titan, reshaping the global drug market landscape.
NXP's potential takeover of Ambarella threatens to consolidate the automotive silicon landscape and reshape the competitive landscape for vision-based AI.
Paramount and Warner Bros. delay their merger until June 2027, stalling a massive industry consolidation play amid legal battles.
Stripe and Advent International's reported $53 billion acquisition offer for PayPal triggers a massive premarket rally for the payments giant.